PraveenRamakrishnanMDMSc

Internal Medicine • Dallas, TX

Hematology/Oncology

MD, MSc

Join to view full profile

Dr. Ramakrishnan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Ramakrishnan's full profile

Already have an account?

Office
5323 Harry Hines Boulevard
Dallas, TX 75390
Phone+1 214-645-4673

Fax+1 214-645-2661
Is this information wrong?

Summary

I am a board certified hematologist-oncologist. I specialize in caring for patients with lymphomas and other hematologic malignancies.

Education & Training

Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 2014 - 2017
Albert Einstein Healthcare NetworkResidency, Internal Medicine, 2012 - 2014
University of Kerala Medical CollegeClass of 2007

Certifications & Licensure

IL State Medical License 2023 - 2026
TX State Medical License 2016 - 2025
PA State Medical License 2011 - 2018
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

3 citations
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023.
Andrew D Zelenetz, Leo I Gordon, Jeremy S Abramson, Ranjana H Advani, Babis Andreadis, Nancy L Bartlett, L Elizabeth Budde, Paolo F Caimi, Julie E Chang, Beth Christia...> ;Journal of the National Comprehensive Cancer Network. 2023 Nov 1
1 citations
Cardiovascular disease and chimeric antigen receptor cellular therapy.
Anjali Rao, Andrew Stewart, Mahmoud Eljalby, Praveen Ramakrishnan, Larry D Anderson Jr, Farrukh T Awan, Alvin Chandra, Srilakshmi Vallabhaneni, Kathleen Zhang, Vlad G ...> ;Frontiers in Cardiovascular Medicine. 2022 Jan 1
77 citations
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021.
Andrew D. Zelenetz, Leo I. Gordon, Julie E. Chang, Beth Christian, Jeremy S. Abramson, Ranjana H. Advani, Nancy L. Bartlett, L. Elizabeth Budde, Paolo Caimi, Sven de V...> ;Journal of the National Comprehensive Cancer Network. 2021 Nov 1
Corrigendum to "The association of leukocyte immunoglobulin-like receptor subfamily B-4 expression in acute myeloid leukemia and central nervous system involvement" [L...
Colin P. Bergstrom, Saurabh Dahiya, Weina Chen, Cheng Cheng Zhang, Hong Zhu, Jingsheng Yan, Yazan F. Madanat, Prapti A. Patel, Madhuri Vusirkala, Praveen Ramakrishnan,...> ;Leukemia Research. 2021 Mar 26
5 citations
The association of leukocyte immunoglobulin-like receptor subfamily B-4 expression in acute myeloid leukemia and central nervous system involvement.
Colin P. Bergstrom, Saurabh Dahiya, Weina Chen, Cheng Cheng Zhang, Hong Zhu, Jingsheng Yan, Yazan F. Madanat, Prapti A. Patel, Madhuri Vusirkala, Praveen Ramakrishnan,...> ;Leukemia Research. 2021 Jan 1
34 citations
Association of Reduced-Intensity Conditioning Regimens With Overall Survival Among Patients With Non-Hodgkin Lymphoma Undergoing Allogeneic Transplant
Nilanjan Ghosh, Sairah Ahmed, Kwang Woo Ahn, Manoj Khanal, Carlos Litovich, Mahmoud Aljurf, Vera Ulrike Bacher, Christopher Bredeson, Narendranath Epperla, Nosha Farha...> ;JAMA Oncology. 2020 Jun 4
23 citations
Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell ...
Narendranath Epperla, Kwang Woo Ahn, Carlos Litovich, Sairah Ahmed, Minoo Battiwalla, Jonathon B. Cohen, Parastoo B. Dahi, Nosha Farhadfar, Umar Farooq, Cesar O. Freyt...> ;Journal of Hematology & Oncology. 2019 Jan 10
Join now to see all

Press Mentions

CAR T-cell Products Among Top Advances in Non-Hodgkin LymphomaJanuary 31st, 2020
Dr. Ramakrishnan on Benefit of CAR T-cell Therapy in MCLJanuary 22nd, 2020